Testing a device to help chronic left heart failure
Part of Heart & circulation clinical trials.
This trial studies a small implant (an “atrial shunt” device) to improve symptoms and heart function in people with chronic left heart failure that stays active despite standard medicines. It focuses on whether the implant is safe and can help you feel better and possibly breathe easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- Your heart failure symptoms have been present for at least 1 month despite stable standard medicines
- You were hospitalized for heart failure within the last 12 months
- Your heart pressure measurements (from a heart catheter) show fluid backup in the lungs/left side of the heart (specific thresholds)
- Your symptoms are moderate to severe (NYHA class II to IV)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called the V-Wave Shunt to see if it can reduce lung congestion and improve symptoms in people with advanced heart failure and a reduced ejection fraction (a measure of how well the heart pumps). It may help if you have severe symptoms despite taking all recommended heart medications.
This trial studies whether the ContraBand device can be safely placed in people with long-term, symptomatic heart failure and reduced heart pumping. It also looks at whether the approach is practical and tolerable, and gathers early safety information.
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
This study is looking at a new treatment for people with heart failure where the heart’s pumping strength is not reduced much (HFpEF or HFmrEF), but pressure inside the heart is high during exercise. It may help relieve symptoms in people who still feel unwell during normal activity despite stable standard treatment.
This trial tests a tiny tube (shunt) placed in the heart to relieve pressure and ease severe shortness of breath. It's for people with a type of heart failure where the heart pumps well but doesn't relax enough.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
Hear when a new Left Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.